Author

Varun V. Prabhu

Chimerix (United States)

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Organism:human· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

Anshu MalhotraiD· 1 shared Dan Zhu· 1 shared Franklin ChieniD· 1 shared Hongying ZhangiD· 1 shared Isabella GershoniD· 1 shared Jingbo LiuiD· 1 shared José E. Velázquez VegaiD· 1 shared Joshua E Allen· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Anshu MalhotraORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

ONC206 demonstrates potent anti-tumorigenic activity and is a potential novel therapeutic strategy for high-risk medulloblastoma

Theophilos Tzaridis, Jingbo Liu, Franklin Chien, Anshu Malhotra, Dan Zhu, Isabella Gershon, Hongying Zhang, José E. Velázquez Vega, Matthew Schniederjan, Teresa Sposito, Peter D. Adams, Joshua E Allen, Varun V. Prabhu, Robert J. Wechsler‐Reya, T. MacDonald

This study shows ONC206 effectively kills medulloblastoma cells and extends survival in mouse models, supporting its potential as a new treatment for high-risk medulloblastoma.

Neuro-Oncology · Mar 6, 2026Peer-reviewedCancer Biology